1. Arron SL Xu is presently the Associate Scientific Director at the Biopharmaceutical division of Intertek (CA, USA). He received a PhD in biochemistry from the University of Sydney, Australia, and has been active in the field of analytical biochemistry with primary focus on bioanalytical and bioassay technology development in support of biomarker discovery and development for translational and clinical programs, high-throughput drug screening and immunochemistry for biologics development with extensive...
2. Jessica Weant studied genetics at University of California, Davis (USA) and is presently a Senior Project Analyst at the biopharmaceutical division of Intertek. Her primary focus is on method development and validation of novel biomarker, pharmacokinetics and anti-drug antibody assays.